Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Hiroshi Soda"'
Autor:
Yasuhiro Umeyama, Hiroshi Soda, Hiroaki Senju, Ryosuke Ogata, Mizuki Iwanaga, Hiroko Hayashi, Hirokazu Taniguchi, Shinnosuke Takemoto, Takahiro Takazono, Noriho Sakamoto, Yuichi Fukuda, Hiroshi Mukae
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 865-873 (2024)
Introduction: This case report presents the successful detection of an EGFR exon 19 deletion using virtual bronchoscopic navigation (VBN) and endobronchial ultrasound with guide sheath (EBUS-GS) brushing, integrated with highly sensitive next-generat
Externí odkaz:
https://doaj.org/article/2a609ed9e32f4ea590860a6a92878759
Autor:
Fumiko Hayashi, Kazumasa Akagi, Hirokazu Taniguchi, Toyoshi Matsutake, Hiromi Kawahara, Ichiro Sekine, Hiroshi Gyotoku, Shinnosuke Takemoto, Hiroshi Soda, Kazuto Ashizawa, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 14, Iss 36, Pp 3556-3560 (2023)
Abstract Lung spindle cell carcinoma is an aggressive subtype of pleomorphic lung cancer resistant to cytotoxic chemotherapy. Programmed cell death‐1 (PD‐1) inhibitors have been reported to have clinical effects in patients with spindle cell carc
Externí odkaz:
https://doaj.org/article/b58ed8ee3b224b079a3224e4769cff4c
Autor:
Ou Yamaguchi, Norimitsu Kasahara, Hiroshi Soda, Hisao Imai, Ichiro Naruse, Hiroyuki Yamaguchi, Miki Itai, Kohei Taguchi, Megumi Uchida, Noriaki Sunaga, Toshitaka Maeno, Koichi Minato, Hiromi Tomono, Daiki Ogawara, Hiroshi Mukae, Yu Miura, Ayako Shiono, Atsuto Mouri, Hiroshi Kagamu, Kyoichi Kaira
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Circulating tumor DNA (ctDNA) provides molecular information on tumor heterogeneity. The prognostic usefulness of ctDNA after first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are limited. Therefore, the pr
Externí odkaz:
https://doaj.org/article/136751bf535d4857a7d70d282fd7c6bf
Autor:
Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, Takaya Ikeda, Seiji Nagashima, Kazumasa Akagi, Sawana Ono, Yasuhiro Umeyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Yasushi Hisamatsu, Ryotaro Morinaga, Ryuta Tagawa, Ryosuke Ogata, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Katsumi Nakatomi, Fumiko Hayashi, Nanae Sugasaki, Akitoshi Kinoshita, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 14, Iss 28, Pp 2890-2894 (2023)
Abstract Introduction Combined treatment using anti‐programmed death‐ligand 1 antibody (anti‐PD‐L1) and platinum‐etoposide is the current standard first‐line treatment for patients with extensive‐stage (ES) small cell lung cancer (SCLC)
Externí odkaz:
https://doaj.org/article/58002b57502d40c3b42c6726aa5a9340
Autor:
Ryuta Tagawa, Hiroshi Soda, Yosuke Dotsu, Hiroaki Senju, Satoshi Irifune, Masataka Yoshida, Shota Nakashima, Asuka Umemura, Keisuke Iwasaki, Hirokazu Taniguchi, Shinnosuke Takemoto, Yuichi Fukuda, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 14, Iss 14, Pp 1320-1324 (2023)
Abstract Hypertrophic osteoarthropathy (HOA) is a paraneoplastic syndrome, the exact pathogenesis of which remains to be elucidated. The case of a 69‐year‐old man who developed intractably painful HOA secondary to lung cancer is presented. Contra
Externí odkaz:
https://doaj.org/article/3835d5718ef445bcb8bb6aec387e83f4
Autor:
Ryosuke Ogata, Hiroshi Soda, Hiroaki Senju, Masaki Fujioka, Midori Shimada, Koki Yamashita, Satoshi Irifune, Ryuta Tagawa, Yosuke Dotsu, Keisuke Iwasaki, Hirokazu Taniguchi, Shinnosuke Takemoto, Yuichi Fukuda, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 13, Iss 19, Pp 2812-2816 (2022)
Abstract Extraskeletal myxoid chondrosarcoma (EMCS) is an undifferentiated mesenchymal malignancy; however, its immune microenvironment remains to be elucidated. The case of a 34‐year‐old woman who developed EMCS metastasizing to the pleura is pr
Externí odkaz:
https://doaj.org/article/a21fc35aa6c24911b5adf1ac1b07f36d
Autor:
Kazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, Takuya Yamazaki, Sawana Ono, Hiromi Tomono, Takayuki Suyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Hiroyuki Yamaguchi, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Takashi Mizowaki, Yoshio Monzen, Takaya Ikeda, Seiji Nagashima, Yutaro Tasaki, Daisuke Nakamura, Kazutoshi Komiya, Katsumi Nakatomi, Eisuke Sasaki, Koichi Hirakawa, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 13, Iss 16, Pp 2404-2409 (2022)
Abstract Background Etoposide plus cisplatin (EP) combined with concurrent accelerated hyperfractionated thoracic radiotherapy (AHTRT) is the standard treatment strategy for unresectable limited‐disease (LD) small cell lung cancer (SCLC), which has
Externí odkaz:
https://doaj.org/article/e98bad858982435187389e1927d39f13
Publikováno v:
Acute Medicine & Surgery, Vol 10, Iss 1, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/9d4efffde51647f48010f48353cd3970
Autor:
Ryosuke Ogata, Hiroshi Soda, Yasuhiro Tanaka, Hiroaki Senju, Midori Shimada, Koki Yamashita, Shota Nakashima, Asuka Umemura, Masataka Yoshida, Takuya Hara, Saeko Jinnai, Keisuke Iwasaki, Yuichi Fukuda, Hiroyuki Yamaguchi, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 13, Iss 1, Pp 133-136 (2022)
Abstract How Epstein–Barr virus (EBV)‐positive diffuse large B‐cell lymphoma (DLBCL) occasionally occurs following chronic inflammation remains to be elucidated. The case of a 57‐year‐old man who developed pulmonary EBV‐positive DLBCL fro
Externí odkaz:
https://doaj.org/article/b61746868d1048ba9d655c3efbd480dc
Autor:
Takaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, Hiroshi Gyotoku, Hirokazu Taniguchi, Midori Shimada, Yosuke Dotsu, Yasuhiro Umeyama, Hiromi Tomono, Takeshi Kitazaki, Masaaki Fukuda, Hiroshi Soda, Hiroyuki Yamaguchi, Minoru Fukuda, Hiroshi Mukae
Publikováno v:
Thoracic Cancer, Vol 11, Iss 7, Pp 1972-1978 (2020)
Background The aim of this study was to assess the efficacy and safety of amrubicin for previously treated malignant pleural mesothelioma. Methods The eligibility criteria were: previously treated unresectable malignant pleural mesothelioma; performa
Externí odkaz:
https://doaj.org/article/b8beb7e2f14e48d293606d434ed3eea7